<\/p>\n
Kenacort<\/strong> is an oral tablet from Abbott Healthcare containing triamcinolone acetonide 4 mg tablets<\/strong> — a medium-potency synthetic glucocorticoid<\/strong> with strong anti-inflammatory and immunosuppressive activity and almost no mineralocorticoid (fluid-retaining) effect<\/strong>. Used for systemic anti-inflammatory therapy across rheumatoid arthritis, lupus, asthma, IBD, vasculitis, allergic reactions and other inflammatory and autoimmune conditions. Standard adult anti-inflammatory dose: 4–48 mg\/day<\/strong> in 1–4 divided doses, titrated to response. Triamcinolone 4 mg is approximately equivalent to prednisolone 5 mg (potency ratio ~5). Never stop abruptly after more than 2–3 weeks of daily use<\/strong> — the drug suppresses the body's own cortisol production (HPA-axis suppression) and abrupt withdrawal can precipitate adrenal crisis. Always taper under medical supervision. Common side effects: weight gain, raised blood sugar, raised blood pressure, mood change, bone loss, increased infection risk, cataract.<\/p>\n<\/div>\n <\/p>\n \ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n Kenacort is an oral tablet manufactured by Abbott Healthcare containing triamcinolone acetonide<\/strong> — a synthetic corticosteroid in the glucocorticoid class. Glucocorticoids are the most powerful broad-spectrum anti-inflammatory and immunosuppressive drugs available, with effects across almost every tissue and organ system.<\/p>\n Kenacort is the original Indian-market triamcinolone tablet from Abbott Healthcare. The 4 mg tablet is the only oral strength stocked — doses are built up by combining tablets (e.g. four 4 mg tablets = 16 mg daily). Available in 15, 30, 60, 90 and 180 tablet packs to support both short anti-inflammatory courses and longer-term low-dose maintenance.<\/p>\n Triamcinolone 4 mg is approximately equivalent to prednisolone 5 mg (potency ratio ~5). The physiological daily cortisol output of a healthy adult is approximately 5–7.5 mg of prednisolone-equivalent — any dose above that is “supraphysiological” and begins to suppress the hypothalamic-pituitary-adrenal (HPA) axis.<\/p>\n Why triamcinolone instead of prednisolone?<\/strong> Triamcinolone has almost no mineralocorticoid (fluid-retaining, sodium-retaining) effect<\/strong> compared with prednisolone or hydrocortisone. This makes it a sensible oral choice in patients with poorly-controlled hypertension, congestive heart failure, severe oedema, or known intolerance of fluid retention on prednisolone. The trade-off is a slightly higher rate of muscle weakness (steroid myopathy) at high doses, particularly in older patients.<\/p>\n Triamcinolone enters cells, binds the intracellular glucocorticoid receptor<\/strong>, and the receptor-drug complex translocates to the nucleus where it alters transcription of hundreds of genes. The end result is a broad dampening of the inflammatory cascade:<\/p>\n Clinical onset (oral): symptomatic relief within hours to 1–2 days<\/strong> for most inflammatory conditions. Peak anti-inflammatory effect within 4–72 hours.<\/p>\n Kenacort is used across a wide range of inflammatory and autoimmune conditions. Because of its very low mineralocorticoid activity, it is particularly useful when fluid retention or sodium retention is a concern.<\/p>\n Kenacort is niet<\/strong> appropriate for: undiagnosed joint pain, isolated mild eczema (topicals first), or any condition where shorter-acting prednisolone is preferred for tighter dose-titration.<\/p>\n Kenacort is supplied at 4 mg tablets<\/strong>. Adult anti-inflammatory dosing typically ranges from 4 to 48 mg per day in 1–4 divided doses, titrated to clinical response.<\/p>\nWaarom bestellen bij MedsBase<\/h3>\n
What Is Kenacort?<\/h2>\n
How Does Kenacort Work?<\/h2>\n
\n
Toepassingen en Indicaties<\/h2>\n
\n
Kenacort Dosage and How to Take<\/h2>\n
Typical starting doses by indication<\/h3>\n